MMSI CEO receives 28,198-share RSU equity award

Aronson Martha Goldberg reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Aronson Martha Goldberg reported acquisition or exercise transactions in this Form 4 filing.

Merit Medical Systems director and President and CEO Martha Goldberg Aronson reported an equity award of 28,198 shares of common stock in the form of restricted stock units. These RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, contingent on her continued service. After this grant, she directly holds 47,792 common shares, aligning a portion of her compensation with the company’s future performance.

Insider Trade Summary

Grant/Award: 28,198 shares

Grant/Award 1 txn

Insider Aronson Martha Goldberg

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, No Par Value	28,198	$0.00	$0.00

Holdings After Transaction: Common Stock, No Par Value — 47,792 shares (Direct)

Footnotes (1)

1. F1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MMSI President and CEO Martha Goldberg Aronson report?

Martha Goldberg Aronson reported an equity award of 28,198 restricted stock units in Merit Medical Systems common stock. These RSUs are a form of compensation that convert into shares over time, tying part of her pay to the company’s stock performance and long-term service.

How many MMSI shares does Martha Goldberg Aronson hold after this Form 4 transaction?

After this transaction, Martha Goldberg Aronson directly holds 47,792 shares of Merit Medical Systems common stock. This total includes the newly granted restricted stock units, which vest over three years, and reflects her reported direct ownership position following the award grant.

What are the vesting terms of the MMSI restricted stock units granted to the CEO?

The restricted stock units granted to Martha Goldberg Aronson vest in three equal annual installments over three years. Vesting occurs on each of the first three anniversaries of the grant date, and each RSU converts into one share of Merit Medical Systems common stock upon vesting, subject to continued service.

Does the MMSI CEO’s Form 4 transaction involve a stock purchase or sale?

The transaction reflects an equity award, not a market purchase or sale. Martha Goldberg Aronson received 28,198 restricted stock units as compensation, with no cash price per share reported, and the units convert into common stock over time if service-based vesting conditions are met.

How do the CEO’s RSUs in MMSI convert into common stock?

Each restricted stock unit granted to Martha Goldberg Aronson represents the contingent right to receive one share of MMSI common stock. The RSUs convert into shares as they vest in three equal annual installments, assuming she continues in service through each vesting date as specified.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 02:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aronson Martha Goldberg

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	02/26/2026		A		28,198(1)	A	$0	47,792	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.

	/s/ Brian G. Lloyd, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.